Research workspaceUnited States · drugs & devices
Open access
2 sources need attentionView coverage

GDELT news, Publisher feeds may be stale or unavailable. Missing coverage does not mean no activity.

Check source health →
← Back to report

Case & docket entry

Mawhiney v. Novo Nordisk Inc et al.**

A filing contains allegations. It does not establish liability, causation or case value.

Litigation
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Products Liability Litigation
Category
Multidistrict Litigation
Law firms
Aylstock Witkin Kreis Overholtz PLLC
Court
See original filing
Docket number
See original filing
Report observation date
2026-03-12
Entry publication date
Not independently verified
Entry type
Source-listed plaintiff filing

Document viewer

The original public document is available through the source’s viewer. Open it to read the filing in full.

Open original filing viewer ↗